Applied DNA Sciences

ADNAS | Crime fighting has never had a weapon like this.

Launch date

1983

Employees

Market cap

Enterprise valuation

€5m (Public information from Sep 2024)

Town of Brookhaven New York (HQ)

http://adnas.com

https://twitter.com/apdn https://www.facebook.com/111545158923349 https://www.linkedin.com/company/applied-dna-sciences/

View job openings

Revenues, earnings & profits over time

USD	2019	2020	2021	2022	2023	2024	2025
Revenues	5.4m	1.9m	9.0m	18.2m	13.4m	3.5m	5.2m
% growth	38 %	(64 %)	367 %	101 %	(26 %)	(74 %)	48 %
EBITDA	(8.1m)	(12.6m)	(9.7m)	(21.4m)	(10.4m)	-	-
% EBITDA margin	(150 %)	(654 %)	(107 %)	(118 %)	(78 %)	-	-
Profit	(8.6m)	(13.0m)	(14.3m)	(8.3m)	(9.9m)	-	-
% profit margin	(160 %)	(674 %)	(158 %)	(46 %)	(74 %)	-	-
R&D budget	3.0m	3.3m	3.8m	3.9m	3.7m	-	-
R&D % of revenue	55 %	172 %	42 %	22 %	28 %	-	-

Date	Investors	Amount	Round
-	Lihti	N/A	-
Dec 2002	N/A	N/A	IPO
Jun 2009	N/A	$450k	Post IPO Equity
Jul 2011	N/A	$5.0m	Post IPO Equity
Jul 2012	N/A	$1.5m	Post IPO Equity
Jan 2013	Small Business Innovation Research (SBIR)	$150k	Grant
Jul 2013	N/A	$7.5m	Post IPO Equity
Jan 2014	Small Business Innovation Research (SBIR)	$975k	Grant
Jun 2014	N/A	$2.1m	Post IPO Equity
Sep 2014	N/A	$1.8m	Post IPO Debt
Jun 2017	N/A	$1.8m	Post IPO Equity
Nov 2019	N/A	$12.0m	Post IPO Equity
Jan 2021	N/A	$15.0m	Post IPO Equity
Feb 2022	N/A	$4.2m	Post IPO Equity
Aug 2022*	N/A	$12.0m	Post IPO Equity
Feb 2023*	Empire State Development	$1.5m	Grant
Jan 2024*	N/A	$3.4m	Post IPO Equity
May 2024*	N/A	$12.0m	Post IPO Equity
Total Funding		€2.4m

Tech stackLearn more about the technologies and tools that this company uses.

Vandalia Research

ACQUISITION by Applied DNA Sciences Sep 2015

Spindle Biotech

ACQUISITION by Applied DNA Sciences Jul 2023